본문으로 건너뛰기
← 뒤로

Age and Colorectal Cancer Outcomes: A Comparative Analysis Between Patients Younger and Older than 70 Years.

Current oncology (Toronto, Ont.) 2026 Vol.33(2)

Moraes Filho O, Alves Martins BA, de Medeiros Silva AA, Medeiros de Almeida R, Nobrega Dos Santos AC, Oliveira Barbosa C, Gonçalves de Oliveira FBLDS, Colles T, Pereira Araújo WJ, de Sousa JB

📝 환자 설명용 한 줄

Colorectal cancer is predominantly a disease of older adults, yet age-related treatment decisions remain controversial.

🔬 핵심 임상 통계 (초록에서 자동 추출 — 원문 검증 권장)
  • 95% CI 0.54-3.26
  • HR 1.33

이 논문을 인용하기

BibTeX ↓ RIS ↓
APA Moraes Filho O, Alves Martins BA, et al. (2026). Age and Colorectal Cancer Outcomes: A Comparative Analysis Between Patients Younger and Older than 70 Years.. Current oncology (Toronto, Ont.), 33(2). https://doi.org/10.3390/curroncol33020100
MLA Moraes Filho O, et al.. "Age and Colorectal Cancer Outcomes: A Comparative Analysis Between Patients Younger and Older than 70 Years.." Current oncology (Toronto, Ont.), vol. 33, no. 2, 2026.
PMID 41744864

Abstract

Colorectal cancer is predominantly a disease of older adults, yet age-related treatment decisions remain controversial. While chronological age is often used as a criterion for surgical eligibility, it remains unclear whether age alone is an independent predictor of surgical and oncological outcomes. This study evaluated whether age is a significant determinant of outcomes in colorectal cancer patients undergoing surgical resection. This retrospective comparative study analyzed 262 patients (193 younger than 70 years, 69 aged ≥ 70 years) diagnosed with colorectal cancer stages I-IV between 2014 and 2021 at a tertiary single center. Survival analysis was conducted using Kaplan-Meier method and Cox proportional hazards regression. Elderly patients had higher ASA classification ( = 0.0270), higher hypertension prevalence ( < 0.0001), higher ICU admission rates (50.7% vs. 21.2%, < 0.0001), and longer hospital stays (12.6 vs. 7.5 days, = 0.0016). However, elderly patients presented with earlier-stage disease (Stage I + II: 64.2% vs. 46.1%, = 0.0108). After adjustment for confounding factors, age did not significantly impact overall survival (HR = 1.33; 95%CI: 0.54-3.26; = 0.5375) or disease-free survival (HR = 1.61; 95%CI: 0.79-3.29; = 0.1939). Despite differences in clinical presentation and pathological findings, age itself was not an independent predictor of survival outcomes. These findings suggest that treatment decisions in elderly colorectal cancer patients should be informed by individual patient physiology and disease stage rather than chronological age alone.

MeSH Terms

Humans; Colorectal Neoplasms; Aged; Male; Female; Retrospective Studies; Age Factors; Middle Aged; Aged, 80 and over; Treatment Outcome; Adult